Peter Jackson
Executive Director at Infex Therapeutics
A Call to Arms for Antimicrobial Resistance
August 3, 2023
Investment into new antimicrobial therapies has been lacking for decades – and now we’re now paying the price. We don’t have enough drugs to fight the superbugs.
13 min read
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
